GLP-1 side effects and step goals: what the evidence shows

What did @kirstyrebeccasjourney actually say?

The transcript here is brief and a little cryptic. The creator says: "another person, another victim, another one that's caught up in the flip it." The caption, however, does the heavier lifting: she reports "no side effects" on her GLP-1 journey, logs her protein intake, and tracks her daily steps falling short of 10,000. She's using hashtags for both Ozempic and Mounjaro, though the specific medication isn't confirmed in the transcript itself.

The phrase "caught up in the flip it" reads like self-aware commentary on the GLP-1 trend, possibly poking fun at herself for joining the wave of people documenting their weight loss journeys online. It's not a medical claim, and that's worth noting before we go further. The factual territory here sits mostly in the caption, not the spoken words.

Does the science back this up?

Reporting zero side effects on a GLP-1 medication is possible, but it's not typical, especially early on. The evidence is pretty consistent that most people experience something.

The STEP trials for semaglutide (Wilding et al., 2021, New England Journal of Medicine) showed that roughly 74% of participants on semaglutide 2.4mg reported gastrointestinal events, predominantly nausea, vomiting, and diarrhea. These were mostly mild to moderate and tended to cluster in the dose-escalation phase. The SURMOUNT-1 trial for tirzepatide (Jastreboff et al., 2022, New England Journal of Medicine) found similar patterns, with GI side effects reported in around 80% of participants at higher doses.

That said, a meaningful minority of patients do report minimal or no side effects, particularly at lower starting doses or after the body adjusts over several weeks. So "no side effects" is not implausible. It's just not the modal experience, and presenting it without that context could set unrealistic expectations for people just starting out.

What did they get wrong (or right)?

The creator doesn't make any false medical claims here, which is credit where it's due. She's not promising weight loss outcomes, not naming a dose, not telling viewers to take anything. The step-counting and protein tracking are behaviors broadly supported by clinical guidance on GLP-1 use.

Where things get a bit loose is the implicit framing. When someone with 1,300 views says "no side effects" under GLP-1 hashtags, that functions as a data point for people researching whether to start. Without context about dose, duration, or individual variation, it can mislead by omission. The hashtag "semiglutide" is also misspelled, which is minor but worth flagging given that people may be searching for actual medical information.

The protein focus is genuinely good advice. GLP-1 medications reduce appetite, and inadequate protein intake during weight loss accelerates muscle loss. A 2023 paper by Wilding and colleagues in Diabetes, Obesity and Metabolism specifically flagged lean mass preservation as a clinical concern in semaglutide users.

What should you actually know?

If you're starting a GLP-1 medication and expecting zero side effects because someone on TikTok reported none, you may be setting yourself up for a rough surprise. The more useful framing: side effects are common, most are GI-related, and many improve after the first few weeks or with slower dose titration.

Protein intake and physical activity, both things this creator is tracking, are genuinely important. Research from Bilet et al. (2024, Obesity Reviews) reviewed lean mass loss across GLP-1 trials and found that exercise and adequate dietary protein were the most consistently supported strategies for preserving muscle during medication-assisted weight loss.

Step tracking is a reasonable proxy for daily movement, but the 10,000-step target is more cultural than clinical. A 2023 meta-analysis by Stens et al. in the European Journal of Preventive Cardiology found meaningful cardiovascular benefit starting around 7,000 steps per day, with diminishing returns above that threshold. By that measure, her 7,500 steps are not the failure she frames them as.

Bottom line

This video is low-risk from a misinformation standpoint. The creator isn't making outrageous claims. She's logging her day, noting an absence of side effects, and tracking protein and steps. The content is benign, but the framing of "no side effects" deserves context that the video doesn't provide. Side effect profiles on GLP-1 medications vary considerably, and individual anecdotes, however genuine, don't substitute for that broader picture.